LoginSignup
452

Eisai

Stock
Stock
ISIN: JP3160400002
Ticker: 4523
JP3160400002
4523

Price

Price

Historical dividends and forecast

All dividend data

Eisai has so far distributed $1.025 in 2024. The next dividend will be paid on 29.05.2025

$1.212

CHART BY

Frequently asked questions

What is Eisai's market capitalization?

The market capitalization of Eisai is $8.87B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Eisai's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Eisai is 32.22. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Eisai?

Eisai's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.928. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Eisai's stock?

Currently, 13 analysts cover Eisai's stock, with a consensus target price of $48.94. Analyst ratings provide insights into the stock's expected performance.

What is Eisai's revenue over the trailing twelve months?

Over the trailing twelve months, Eisai reported a revenue of $4.88B.

What is the EBITDA for Eisai?

Eisai's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $582.21M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Eisai?

Eisai has a free cash flow of -$250.77M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Eisai's stock?

The 5-year beta for Eisai is 0.32. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Eisai have, and what sector and industry does it belong to?

Eisai employs approximately 11,067 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Eisai's shares?

The free float of Eisai is 267.66M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $8.87B

5Y beta

 0.32

EPS (TTM)

 $0.928

Free Float

 267.66M

P/E ratio (TTM)

 32.22

Revenue (TTM)

 $4.88B

EBITDA (TTM)

 $582.21M

Free Cashflow (TTM)

 -$250.77M

Pricing

1D span
$30.01$30.35
52W span
$43.15$54.07

Analyst Ratings

The price target is $48.94 and the stock is covered by 13 analysts.

Buy

6

Hold

4

Sell

3

Information

Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.

11,067

Biotechnology & Drugs

Health Care

Identifier

ISIN

JP3160400002

Primary Ticker

4523

Knockouts

Join the conversation
Sign upLogin